SuperworthVerrica Pharmaceuticals shares outstanding VRCA
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 21.3M
- On a year earlier
- +124.5%
- more shares
Verrica Pharmaceuticals had 21.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 124.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 14.1M | +109% |
| FY2024 | 6.7M | +45% |
| FY2023 | 4.6M | +13% |
| FY2022 | 4.1M | +49% |
| FY2021 | 2.8M | +10% |
| FY2020 | 2.5M | +1% |
| FY2019 | 2.5M | +0% |
| FY2018 | 2.5M | +772% |
| FY2017 | 285.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 21.3M | +124% | |
| Q1 FY26 | 21.3M | +125% | |
| Q4 FY25 | 14.1M | +109% | |
| Q3 FY25 | 9.5M | +103% | |
| Q2 FY25 | 9.5M | +104% | |
| Q1 FY25 | 9.5M | +104% | |
| Q4 FY24 | 6.7M | +45% | |
| Q3 FY24 | 4.7M | +2% | |
| Q2 FY24 | 4.7M | +1% | |
| Q1 FY24 | 4.6M | +8% | |
| Q4 FY23 | 4.6M | +13% | |
| Q3 FY23 | 4.6M | +14% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Verrica Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.